Mangoceuticals sells 70k shares at $1.50, expands COO role, grants subsidiary control

MANGOCEUTICALS, INC.

Sold 70,000 restricted shares to accredited investor for $105,000 at $1.50/share via exempt private placement.
Expanded COO Amanda Hammer's role to include COO of subsidiary M&P; salary raised to $180,000/year.
Company agreed to issue Jacob Cohen 1.7M common shares and super-voting preferred of M&P for 51% voting control.
Hammer received $15,000 cash bonus within 30 days of amendment effective Feb 6, 2025.

item 3.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Amanda Hammer

Chief Operating Officer

MGRX · MANGOCEUTICALS, INC.

Effective: 2025-02-06
Filed: February 7, 2025, 6:59 PM ET

Pursuant to the Hammer Amendment, Ms. Hammer’s role with the Company was expanded to include serving as Chief Operating Officer of Mango & Peaches Corp.,

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Amanda Hammer changed role as Chief Operating Officer at MANGOCEUTICALS, INC..

Action: expanded
Role: Chief Operating Officer

Exact text from the filing

Pursuant to the Hammer Amendment, Ms. Hammer’s role with the Company was expanded to include serving as Chief Operating Officer of Mango & Peaches Corp.,

View on SEC.gov

MANGOCEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-005457

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.